Pyrazinamide
PYRAZINAMIDE IN TUBERCULOSIS
Experience with Pyrazinamide
Factors Affecting the Pharmacokinetics of Pyrazinamide and Its Metabolites in Patients Coinfected with HIV and Implications for Individualized Dosing
Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis
Pyrazinamide.